Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Cerevel Therapeutics Holdings, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +14 vs. Q3 2021
- Shares held
- 118.6M
- −518.3K (−0.4%) vs. Q3 2021
- Total value
- $3.84B
- +$331.0M (+9.4%) vs. Q3 2021
- New holders
- 27
- 43 more added
- Sold out
- 13
- 27 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CERE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $1.16K |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 2 | $20.7K |
| Q2 2024 | 231 | $6.42B |
| Q1 2024 | 210 | $6.67B |
| Q4 2023 | 195 | $6.61B |
| Q3 2023 | 119 | $3.07B |
| Q2 2023 | 125 | $4.41B |
| Q1 2023 | 119 | $3.30B |
| Q4 2022 | 125 | $4.23B |
| Q3 2022 | 115 | $3.76B |
| Q2 2022 | 109 | $3.28B |
| Q1 2022 | 107 | $4.27B |
| Q4 2021 | 107 | $3.84B |
| Q3 2021 | 94 | $3.51B |
| Q2 2021 | 82 | $2.65B |
| Q1 2021 | 62 | $1.37B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Cerevel Therapeutics Holdings, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 3,113,333 | $100.9M | 0.19% | 00.0% | Unchanged |
| BlackRock Inc. | 3,484,657 | $113.0M | 0.00% | +121,379+3.6% | Added |
| Vanguard Group Inc | 4,801,837 | $155.7M | 0.00% | +108,678+2.3% | Added |
| Perceptive Advisors LLC | 5,086,727 | $164.9M | 2.55% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 6,000,922 | $194.6M | 0.02% | +160,191+2.7% | Added |
| FMR LLC | 19,509,813 | $632.5M | 0.05% | +703,184+3.7% | Added |
| Bain Capital Investors LLC | 60,632,356 | $1.97B | 23.51% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −424,767−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −194,400−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −141,400−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −53,370−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −43,204−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −25,942−100.0% | Sold out |
| Bellwether Advisors, LLC | 0 | $0 | 0.00% | −17,197−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −8,525−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |